Mullard, A. (2025). FDA approves a rare novel–novel oncology combination that pairs a first-in-class FAK inhibitor with a MEK–RAF glue inhibitor. Nature Reviews Drug Discovery. https://doi.org/10.1038/d41573-025-00086-y